Literature DB >> 31489318

Adjuvant therapy after radical surgery for hepatocellular carcinoma: still an unmet need.

Yasunori Minami1, Masatoshi Kudo1.   

Abstract

Entities:  

Year:  2019        PMID： 31489318      PMCID： PMC6700001          DOI： 10.21037/hbsn.2019.04.05

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  14 in total

1.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

Review 2.  Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

4.  Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.

Authors:  Haruhiko Yoshida; Yasushi Shiratori; Masatoshi Kudo; Shuichiro Shiina; Toshihiko Mizuta; Masamichi Kojiro; Kyosuke Yamamoto; Yukihiro Koike; Kenichi Saito; Nozomu Koyanagi; Takao Kawabe; Seiji Kawazoe; Haruhiko Kobashi; Hiroshi Kasugai; Yukio Osaki; Yasuyuki Araki; Namiki Izumi; Hiroko Oka; Kunihiko Tsuji; Joji Toyota; Toshihito Seki; Toshiya Osawa; Naohiko Masaki; Masao Ichinose; Masataka Seike; Akihisa Ishikawa; Yoshiyuki Ueno; Kazumi Tagawa; Ryoko Kuromatsu; Shotaro Sakisaka; Hiroshi Ikeda; Hidekatsu Kuroda; Hiroyuki Kokuryu; Tatsuya Yamashita; Isao Sakaida; Tetsuo Katamoto; Kentaro Kikuchi; Minoru Nomoto; Masao Omata
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

Review 5.  Surgery and Hepatocellular Carcinoma.

Authors:  Nobuhisa Akamatsu; Umberto Cillo; Alessandro Cucchetti; Matteo Donadon; Antonio Daniele Pinna; Guido Torzilli; Norihiro Kokudo
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

Review 6.  Current Technical Issues for Surgery of Primary Liver Cancer.

Authors:  Yoshikuni Kawaguchi; Goro Honda; Itaru Endo; Daniel Cherqui; Norihiro Kokudo
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

7.  Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.

Authors:  Jordi Bruix; Tadatoshi Takayama; Vincenzo Mazzaferro; Gar-Yang Chau; Jiamei Yang; Masatoshi Kudo; Jianqiang Cai; Ronnie T Poon; Kwang-Hyub Han; Won Young Tak; Han Chu Lee; Tianqiang Song; Sasan Roayaie; Luigi Bolondi; Kwan Sik Lee; Masatoshi Makuuchi; Fabricio Souza; Marie-Aude Le Berre; Gerold Meinhardt; Josep M Llovet
Journal:  Lancet Oncol       Date:  2015-09-08       Impact factor: 41.316

Review 8.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.

Authors:  Kiwamu Okita; Namiki Izumi; Osamu Matsui; Katsuaki Tanaka; Shuichi Kaneko; Hisataka Moriwaki; Kenji Ikeda; Yukio Osaki; Kazushi Numata; Kohei Nakachi; Norihiro Kokudo; Kazuho Imanaka; Shuhei Nishiguchi; Takuji Okusaka; Yoichi Nishigaki; Susumu Shiomi; Masatoshi Kudo; Kenichi Ido; Yoshiyasu Karino; Norio Hayashi; Yasuo Ohashi; Masatoshi Makuuchi; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2014-04-13       Impact factor: 7.527
View more
  3 in total

Review 1.  Intrahepatic recurrence of hepatocellular carcinoma after resection: an update.

Authors:  Maria Tampaki; George Vasileios Papatheodoridis; Evangelos Cholongitas
Journal:  Clin J Gastroenterol       Date:  2021-03-27

2.  Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients.

Authors:  Lee Jin Lim; Lay Hiang Ling; Yu Pei Neo; Alexander Y F Chung; Brian K P Goh; Pierce K H Chow; Chung Yip Chan; Peng Chung Cheow; Ser Yee Lee; Tony K H Lim; Samuel S Chong; London L P J Ooi; Caroline G Lee
Journal:  J Cancer       Date:  2021-03-30       Impact factor: 4.207

3.  Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study.

Authors:  Kongying Lin; Fuqun Wei; Qizhen Huang; Zisen Lai; Jinyu Zhang; Qingjing Chen; Yabin Jiang; Jie Kong; Shichuan Tang; Jianhuai Lin; Yufeng Chen; Jinhong Chen; Yongyi Zeng
Journal:  J Hepatocell Carcinoma       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.